Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

NCT03175432 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

BRAF V600 Wild Type
Clinical Stage IV Cutaneous Melanoma AJCC v8
Intracranial Melanoma
Metastatic Malignant Neoplasm in the Brain
Metastatic Melanoma
Pathologic Stage IV Cutaneous Melanoma AJCC v8
Refractory Melanoma

Interventions

DRUG: Atezolizumab
BIOLOGICAL: Bevacizumab
DRUG: Cobimetinib
PROCEDURE: Quality-of-Life Assessment

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]